Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT04170270

Oral Omeprazole in Bleeding Peptic Ulcer

Oral Versus Intravenous Omeprazole in Management of Bleeding Peptic Ulcer: Randomized Controlled Trial

Sponsor: Assiut University

Interventions Omeprazole

Updated 5 times since 2019 Last updated: Nov 22, 2019 Started: Nov 30, 2019 Primary completion: Dec 31, 2020 Completion: Jan 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Bleeding Peptic Ulcer and is currently ongoing. Assiut University leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Not Yet Recruiting EARLY_PHASE1
Dec 2019 — Jan 2021 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.